Hyperfine News

Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023

Publications

Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023

November 20, 2023

Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients

Publications

Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients

November 02, 2023

Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives

Company

Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives

October 10, 2023

Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences

FDA

Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences

October 09, 2023

Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System

Collaboration

Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System

August 09, 2023

Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer

Company

Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer

July 18, 2023

Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care

Collaboration

Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care

July 11, 2023

Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR Education

Collaboration

Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR Education

June 08, 2023

Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative <em>Swoop<sup><sub>®</sub></sup> Portable MR Imaging<sup><sub>®</sub></sup></em> System in Low and Middle-Income Countries

Collaboration

Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop^_® Portable MR Imaging^_® System in Low and Middle-Income Countries

May 18, 2023

Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging

FDA

Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging

February 28, 2023

Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations

Company

Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations

February 21, 2023

Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System

FDA

Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System

February 13, 2023

Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a Thrombectomy

Company

Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a Thrombectomy

February 09, 2023

Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer

Company

Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer

February 08, 2023

Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage at ISMRM with Twelve Abstract Inclusions

Company

Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage at ISMRM with Twelve Abstract Inclusions

February 06, 2023

Hyperfine Names Maria Sainz President and Chief Executive Officer

Company

Hyperfine Names Maria Sainz President and Chief Executive Officer

October 06, 2022

Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm

Partner News

Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm

July 26, 2022

Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Sequence with Faster Scan Time to Benefit Pediatric Patients

Company

Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Sequence with Faster Scan Time to Benefit Pediatric Patients

July 14, 2022

Hyperfine Receives FDA Clearance for Two New Imaging Sequences

FDA

Hyperfine Receives FDA Clearance for Two New Imaging Sequences

June 21, 2022

Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification

Company

Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification

June 14, 2022

Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities

Collaboration

Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities

February 16, 2022

Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

Company

Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

February 08, 2022

M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

Collaboration

M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

January 19, 2022

Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market

Company

Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market

December 22, 2021

Hyperfine Appoints New Board of Directors

Company

Hyperfine Appoints New Board of Directors

December 13, 2021

Hyperfine Announces Expansion into Canadian Market with Medical Device License Issued by Health Canada

Company

Hyperfine Announces Expansion into Canadian Market with Medical Device License Issued by Health Canada

December 09, 2021

Hyperfine Partners With Madonna’s Charitable Organization, Raising Malawi, to Increase Access to High Quality Healthcare for Children

Collaboration

Hyperfine Partners With Madonna’s Charitable Organization, Raising Malawi, to Increase Access to High Quality Healthcare for Children

December 07, 2021

Hyperfine Receives FDA Clearance for Deep Learning Portable MRI, Defining the Future of Life-Saving Diagnostics

FDA

Hyperfine Receives FDA Clearance for Deep Learning Portable MRI, Defining the Future of Life-Saving Diagnostics

November 29, 2021

Hyperfine, Liminal Sciences, and HealthCor Catalio Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination

Company

Hyperfine, Liminal Sciences, and HealthCor Catalio Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination

November 29, 2021

Hyperfine Announces Receipt of Additional $3.3 Million Grant to Improve Access to Neonatal and Pediatric Brain Imaging in Low-Resource Settings Globally

Collaboration

Hyperfine Announces Receipt of Additional $3.3 Million Grant to Improve Access to Neonatal and Pediatric Brain Imaging in Low-Resource Settings Globally

November 02, 2021

Hyperfine Appoints Scott White as Chief Commercial Officer

Company

Hyperfine Appoints Scott White as Chief Commercial Officer

October 28, 2021

Hyperfine Announces Formation of Medical Advisory Board

Company

Hyperfine Announces Formation of Medical Advisory Board

October 14, 2021

Hyperfine Announces Plans for Global Expansion Starting with Launches in the United Kingdom and Pakistan

Company

Hyperfine Announces Plans for Global Expansion Starting with Launches in the United Kingdom and Pakistan

September 28, 2021

Hyperfine Announces Analyst and Investor Meeting on September 27

Company

Hyperfine Announces Analyst and Investor Meeting on September 27

September 13, 2021

Hyperfine Appoints Kyla Pavlina, J.D., as Chief People Officer

Company

Hyperfine Appoints Kyla Pavlina, J.D., as Chief People Officer

August 31, 2021

Hyperfine’s Portable MRI System Demonstrates High Accuracy for Detection of Brain Hemorrhage in Study Published in Nature Communications

Publications

Hyperfine’s Portable MRI System Demonstrates High Accuracy for Detection of Brain Hemorrhage in Study Published in Nature Communications

August 25, 2021

Hyperfine Announces Appointment of Alok Gupta as Chief Financial Officer

Company

Hyperfine Announces Appointment of Alok Gupta as Chief Financial Officer

August 23, 2021

Fast Company Recognizes Jonathan M. Rothberg in its “Most Creative People in Business” List

Recognition

Fast Company Recognizes Jonathan M. Rothberg in its “Most Creative People in Business” List

August 12, 2021

Hyperfine, Inc., creator of the first FDA-cleared portable MRI device, and Liminal Sciences, Inc. to be listed on Nasdaq through a business combination with HealthCor Catalio Acquisition Corp.

Company

Hyperfine, Inc., creator of the first FDA-cleared portable MRI device, and Liminal Sciences, Inc. to be listed on Nasdaq through a business combination with HealthCor Catalio Acquisition Corp.

July 08, 2021

Hyperfine Names Paykel and Teisseyre to Executive Leadership Positions

Company

Hyperfine Names Paykel and Teisseyre to Executive Leadership Positions

June 30, 2021

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Company

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

June 15, 2021

Hyperfine Names Veteran Medical Device and Innovation Leader Dave Scott President and CEO

Company

Hyperfine Names Veteran Medical Device and Innovation Leader Dave Scott President and CEO

June 08, 2021